Clinical Trial Update: NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder [Phase 2]

View source ↗

Summary

Phase 2 trial testing two doses of botulinum toxin type A for neurogenic overactive bladder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity
• Overactive Bladder

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Overactive Bladder | Phase 2 | Status: TERMINATED